2004
DOI: 10.4088/jcp.v65n0105
|View full text |Cite
|
Sign up to set email alerts
|

Mental Health Service Utilization by Borderline Personality Disorder Patients and Axis II Comparison Subjects Followed Prospectively for 6 Years

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

15
149
2
12

Year Published

2006
2006
2018
2018

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 257 publications
(181 citation statements)
references
References 0 publications
15
149
2
12
Order By: Relevance
“…Psychosocial impairment, particularly with social relationships, also seems relatively stable over time [6] Research has also examined the impact that PD diagnoses have on psychiatric and medical treatment utilization. Previous studies on individuals with PD diagnoses demonstrated that BPD individuals differ in usage of outpatient, inpatient, and psychopharmacologic treatments when compared to other PD groups [7,8] and when compared to major depression groups without PD [9]. Patients with BPD also receive more psychotropic medications when compared to all other non-PD diagnostic groups [10,11].…”
Section: Introductionmentioning
confidence: 96%
“…Psychosocial impairment, particularly with social relationships, also seems relatively stable over time [6] Research has also examined the impact that PD diagnoses have on psychiatric and medical treatment utilization. Previous studies on individuals with PD diagnoses demonstrated that BPD individuals differ in usage of outpatient, inpatient, and psychopharmacologic treatments when compared to other PD groups [7,8] and when compared to major depression groups without PD [9]. Patients with BPD also receive more psychotropic medications when compared to all other non-PD diagnostic groups [10,11].…”
Section: Introductionmentioning
confidence: 96%
“…Although drug treatment is widely used in the treatment of personality disorder -indeed, polypharmacy is sadly almost the norm in borderline personality disorder 22 -there is little evidence of substantial benefit either in the short or longer term with any of the drugs -antipsychotics, mood stabilisers and selective serotonin reuptake inhibitors (SSEIs) commonly used to treat any of the individual personality disorders. This does not mean drugs are not of help at times; it is just that the evidence base is very limited at present and may have been oversold.…”
Section: Drug Treatmentsmentioning
confidence: 99%
“…l trastorno límite de la personalidad (TLP) supone un considerable sufrimiento tanto para la persona que lo padece como para su entorno, así como un elevado consumo de recursos sanitarios (Bender et al, 2001;Zanarini, Frankenburg, Hennen & Silk 2004), no solo por su prevalencia del 1-2% en población general (APA, 2000;Lieb, Zanarini, Schmahl, Linehan & Bohus, 2004) y del 10-20% en pacientes psiquiátricos (Torgersen, Kringlen, Cramer, 2001), sino también por su naturaleza (Linehan, Heidi, Heard, Hubert & Armstrong, 1993). Las características del comportamiento lí-mite y la resistencia a los tratamientos farmacológicos hacen de la psicoterapia el elemento clave para la mejoría de estos pacientes.…”
unclassified